Patent details

EP3458053 Title: USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3458053
WO Application Number:
US2017033688
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17800310.9
WO Publication Number:
WO2017201501
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
19/05/2017
Grant date:
08/12/2021
EP Publication Date:
27/03/2019
WO Publication Date:
23/11/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
25/02/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
08/12/2021
EP B1 Publication Date:
08/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
18/05/2037
Lapsed By Expiration Date:
Patent Validated Date:
10/03/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
15/03/2022
 
 

 

Name:
Biohaven Therapeutics Ltd.
Address:
215 Church Street, 06510, New Haven, CT, United States of America (US)

Historical Applicant/holder

From:
15/03/2022
To:
15/03/2022

 

Name:
Biohaven Pharmaceutical Holding Company Ltd.
Address:
215 Church Street, 06510, New Haven, CT, United States of America (US)

From:
08/12/2021
To:
15/03/2022

 

Name:
Biohaven Pharmaceutical Holding Company Ltd.
Address:
234 Church Street Suite 301, New Haven, CT 06520, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
09/03/2022
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Inventor

Name:
CORIC, Vladimir
Address:
New Haven Connecticut 06520, United States of America (US)

Priority

Priority Patent Number:
201662339433 P
Priority Date:
20/05/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/428; C07D 277/82; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
16/22
Publication date:
20/04/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
11/22
Publication date:
16/03/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
49/21
Publication date:
08/12/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202150
Publication date:
15/12/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202149
Publication date:
08/12/2021
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202200639A
Date Registered:
15/03/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
A. Rivière
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202200639B
Date Registered:
15/03/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
A. Rivière
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Biohaven Therapeutics Ltd.
Address:
215 Church Street, 06510, New Haven, CT, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/05/2026
Annual Fee Number:
10
Annual Fee Amount:
400 Euro
Last Annual Payment Date:
14/03/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
340 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
09/03/2022 Outgoing Correspondence Letter no formal defects 1 PDF /8/3/0/1/5/0800751038/docs/ep17800310.9_1_467017l271.pdf
25/02/2022 Claims First filed claims 2 PDF /8/3/0/1/5/0800751038/docs/ep17800310.9_0_claims20220225094505341.pdf